Afteraoi Kaposi1) designated the condition characterized by fever, toxic mani festations and cutaneous lesions resembling those of erysipelas disseminatus as lupus erythematosus disseminatus 94 years ago and Osler2) first emphasized the significance of the systemic manifestations of the disease 71 years ago, Pale was first to make a systematic review of cerebral involvements and refered to the now well-known neurological signs of this disease-toxic psychosis, convulsion and scattered neurological findings. Peripheral neuritis, was first described in this disease by Hepteinstall.and. Sowry4) in 1952 and Malamud and Savers) in 1954 summarized neuropathological findings.
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Harvey et al.6) in a review of literature and analysis of their cases, and Clark7)-9) in a series of papers men tioned a variety of neurological signs and symptoms.
Numerous case reports of SLE (systemic lupus erythematosus) with neurological signs and symptoms have also been made over the past ten years.
METHOD OF STUDY
The charts of the patients diagnosed as having systemic lupus erythematosus at The Johns Hopkins Hospital between 1951 and 1964 were screened and those of the patients having positive L-E preparation and at least one of the three major symptoms of the disease-polyarthritis, butterfly skin lesion, renal involve ment in the background of general symptomatology most compatible with SLE were carefully reviewed in regard to the presence of any neuromusculo-retinal abnormalities.
Thus 46 patients were selected. The charts of these patients were studied to investigate the nature of their neuro-muscudo-retinal abnormali ties, the ways of their development and their course and prognosis.
Also the effects of steroid treatment on these abnormalities were studied. 
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In the present study, no attempt was made to reveal the incidence of neuro logical abnormalities of SLE because, of the three reasons.
The first is that very rigid criteria were used for diagnosis of SLE to avoid confusing the issue by including those possibly with diseases other than SLE. The second is that not all the charts of the patients seen in the above-mentioned period were available. The third is that the attempt has been made by others. Each symptom is dealt with in the following sections with illustrative cases, Table  1 Neurological Signs and Symptomes seen in the Patients in the Present Series
Most of the patients had more than 1 sign or symptom.
RESULTS

Convulsive Seizures
It is now well known that convulsive seizures occur not infrequently in the course of SLE. Benett et all0) found incidence ranging from 7 to 31% in 6 large series of patients with SLE. Russell et al.11) reported that among 144 patients with the disease reported in literature up to 1951, 22 had convulsions. Fifteen had convulsions during the terminal stage of the disease. Four had isolated grand mal seizures during the active, preterminal phase. Information is not available in the other three. The same authors reported in their own series, 7 patients with seizures out of 28 with SLE. Two had recurrent attacks of convulsions, preceding by 2 years in 1 case and by several years in the other, the onset of other signs of SLE. In 3 patients, convulsive seizures occurred during the active phases of the disease. They did not recur when SLE was controlled. Two other patients had recurrent convulsions only terminally, one of them in association with oliguria and uremia. Clark and Bailey7) in their review of 100 patients with SLE mentioned 14 patients with seizures, 3 having them terminally.
Fifteen patients in the present series had convulsions and among them only one terminally.
One patient had repeated febrile seizures between age 2 and 10, this being the only one having convulsions before the development of SLE symptoms. All patients but one developed convulsions during active stages of the, disease. Ten had no recurrence after the initial episodes although not on anticonvulsants.
In 2 others they recurred only during relapses of the disease. In others this point is not clear. Ten patients were receiving adrenocorticosteroid treatment at the time of the initial convulsion. In 1 patient, 16 attacks of con vulsions occurred over 48 hours when ACTH aid cortisone were suddenly with drawn. In contrast, 2 patients had seizures 4 and 5 days respectively after they were started on steroid treatment while other symptoms were subsiding.
Hyper tension and azotemia in 3 patients and hyponatremia in 1 might have precipitated the convulsions.
Thirteen had generalized convulsions while 1 had focal and generalized seizures. Electroencephalogram taken immediately following con vulsions in 4 patients showed no lateralized abnormality or seizure discharge. Ten lumbar punctures were done (twice in 1 patient) and on 3 occassions elevated protein up to 128 mg% was found. On 6 occassions red blood cells up to 86/mm3, white blood cells up to 10/mm3 were noted. No evidence of meningitis or peri pheral neuropathy was present at that times. Case (1) : This female was in good health until March 1955 when at the age of 17, she developed swelling and pain of the ankles and was found to have positive L-E preparations. She was treated with prednisone and noted symp tomatic relief. That summer she had frequent episodes of purpura, especially on lowering doses of steroid. In September, she developed pain, swelling and heat in elbows, fingers, knees and ankles. Also severe epistaxis was noted. This was followed by generalized convulsions with tongue biting. Prednisone was continued and she felt better. She continued to have bleeding tendency and splenectomy had to be done 6 months later. However no more convulsion was noted although no anticonvulsants were given to the patient.
Psychoses
Psychoses are common neurological symptoms of SLE.
Their incidence varies from 9% reported by Jesser et al 21 to 52% by O'Connor.22> In the latter's series of 40 patients, 11 developed acute brain syndrome, 7 schizophrenia, 3 psychotic depression. Eighteen of the 21 patients were receiving steroid at the time of the episode. As a rule, psychoses occurred when steroid dosage was increased to control medical symptoms.
Of eleven previously psychotic patients who subsequently received steroids, 3 had recurrence of psychoses. The remain ing 8 received essentially the same level of cortisone as they had had at the time of their psychoses. The length of the psychotic episodes ranged from hours to months. None remained grossly psychotic for more than 4 months. Comparable series was reported by Stern and Robbins23) who found that of 53 patients, 15 had organic mental syndrome, 6 schizophrenia, 2 psychotic depression and 3 steroid induced psychosis.
Patients previously psychotic while treated with steroids tolerated subsequent courses of therapy with no ill effects. Those with purely organic mental syndrome responded readily to steroid.
In schizophrenic patients psychosis frequently continued, even after all evidence of SLE activity had ceased. and in 3 they were permanent. Relatively sudden development of hemiparesis, paraparesis or other later alizing signs, most probably secondary to vascular accidents is not uncommon in the course of SLE. Twenty-two case reports are found in literature.8 20)27)-39) These include 16 cases of hemiparesis, 5 paraparesis and 1 brain stem signs. The onset of these signs was associated with other signs of active SLE in 11 patients. Of 16 cases with hemiparesis, 11 developed it over several hours to a few days. In two the onset was preceded by convulsive seizures. Paraparesis in 4 cases developed over 3 to 17 days and in 1 case this point is not clear. Six hemiparetics and 3 paraparetics had lumbar punctures and in all of them except 3, cerebrospinal fluid protein was found elevated up to 216 mg%. Other abnor malities such as pleocytosis, elevated pressure, abnormal colloidal gold curve were noted in 3 patients. Eight patients died soon after onset of stroke.
In this series, 10 patients developed stroke. Hemiparesis was noted in 6 (2 had 2 separate episodes of hemiparesis), paraparesis in 1, monoparesis in 1 and hemianopsia in 1. In the 10th patient brain stem signs consisting of severe vertigo, ataxia, intentional tremor of the arm and dysarthria were noted. The age at the onset of initial episodes ranges from 20 to 67. Four were in their thirties, three in their fourties, the other three were 20, 55 and 67 years old respectively. In 6 patients (including 2 with 2 episodes), these signs developed over a few minutes to a few days. In 2 others, the onset was preceded by con vulsive seizures. Five had active SLE and 7 including 2 with 2 episodes were receiving steroid at the onset. Three patients had mild to moderate hyperten sion along with migraine, arteriosclerosis and syphilis respectively. Another patient had positive STS of low titre, possibly a biological false positive. The fifth patient had an episode of dehydration and hypotension preceding the onset of paraparesis.
No patient had overt signs of hemorrhagic tendency. Two patients had signs of arterial insufficiency in the extremities, one having Ray naud's syndrome 6 years before and another gangrene of the toes 1 year before the development of hemiparesis. Lumbar puncture was done at the time of onset of these signs in 6 patients (1 with 2 episodes had 2 lumbar punctures) and except on 1 occassion in which the onset was associated with subarachnoid hemorrhage, cerebrospinal fluid was normal in pressure, protein and number of cells. Two died within 1 month after the onset of stroke and the neurological involvement was the major cause of death. Seven were followed for 5 months to 9 years and no further episodes of lateralizing signs were noted during this period, those present remaining unchanged or regressed. Table  4 Stroke in the Course of SLE Case (3) : In 1953, at age 30, this female was diagnosed as having SLE on the basis of fever, arthritis, lymphadenopathy, leucopenia and hyperglobulinemia.
Subsequently she was repeatedly noted to have positive L-E preparations. In 1958, she had muscular weakness and a muscle biopsy showed hyaline degenera tion. Over 2 years prior to her demise, she noted episode3 of diminished vision of the left eye associated with diziness, tinnitus and headache.
In 1962, she was noted to have gangrene of the toes. Femoral arteriogram showed minimal intimal changes in the superficial femoral and popliteal arteries but no major vessel obstruction.
In June 1963, she suddenly developed weakness of her right arm and aphasia, but these neurological abnormalities rapidly disappeared over the next 4 days in hospital. For 7 days prior to her last admission on September 2, 1963, she complained of intermittent weakness of the right extremities and also of intermittent blindness.
Subsequently her right extremities became com pletely paralysed and sagging of the right side of her face was noted. She became unable to swallow. On admission BP was 124/80, P. 132 reg., T. 101.2, and R. 30. She did not speak but occassionally made grunting sounds. Hori zontal movement of the eyes was minimal with retention of vertical movement. Right extremities were completely paralysed and left partailly paralysed. Lungs, heart and abdomen were unremarkable. No joint or skin lesion was noted.
Abnormal laboratory studies were sedimentation rate of 36 and serum albumin, globulin ratio of 3.5 to 4.6 g%. Cerebrospinal fluid was normal. She became completely unresponsive over the next 3 days and expired on the 6th hospital day. She was on steroid continuously for 5.5 years before death. Autopsy revealed that left internal carotid artery, middle cerebral artery and anterior cerebral artery were all occupied by a continuous, firm thrombus.
The right vertebral artery and basilar artery were also thrombosed. Extensive ischemic infarction was noted in left cerebral hemisphere, brain stem and cerebellum. No evidence of arteriosclerosis was noted. Microscopic examination failed to reveal any additional change.
Specifically no vascular lesion was noted beyond the thromboses.
Case (4) In the present series, spinal fluid pleocytosis of unknown etiology ranging from 10 to 1470 was noted in 3 patients.
In all, meningeal signs such as headache, vomitting, lethargy and fever were noted at the same time. Mononuclears pre dominated over polymorphnuclear cells in all 3, although in 1 patient polymor phnuclears were more numerous at the peak. In this series, there were 9 patients with muscle pain and 4 patients with muscle weakness. Five patients had myalgia in active stages of the disease and in the remaining four in chronic stages. The pain was noted in the larger proximal muscles of the extremities in all 5 patients in whom the site of the pain was clearly recorded. Five of the 9 patients were noted to have muscle tenderness on examination. One had a muscle biopsy while having muscle pain and tenderness and this revealed perivascular infiltration of lymphocytes and plasma cells. Although in most patients, muscle pain and tenderness disappeared in days to weeks, in 1 patient muscle pain persisted over 4 years. Five patients had muscle biopsy and interstitial myositis in 3, hyaline necrosis of fibers in 1 and foci of muscular atrophy and fibrosis with associated lymphocytic infiltration in 1 were noted Case (3) previously described also had myopathy. It is now described in more detail. papilledema. The cytoid bodies were interpreted as manifestations of a gener alized toxemia as they appeared only after the patients developed rather marked systemic manifestations.
Geertruyden et al76) reported a case of SLE in which they followed the retinal changes carefully over a year. They noted a parallelism between the retinal spots and systemic symptoms as well as a cyclic evolution of the cytoid bodies-appearance of a soft spot, sharpening of the ophthalmoscopic appearance and period of stabilization, regression and eventual disappearance without leaving a trace. The duration of the cycle and size of the lesion were variable for different elements, but they never attained size bigger than one sixth the disc diameter.
Dubois et al.56) found incidence of cytoid bodies and retinal hemorrhages to be 9.6 and 10.5% respectively among 520 cases of SLE.
In this series, cytoid bodies were noted in 9 patients, among whom three had, in addition, other retinal changes including hemorrhages, exudates, occlusion of the retinal vessels and aneurysms with absence of hypertension and diabetes mellitus. Two other patients had the similar retinal changes without cytoid bodies, but both were hypertensive. The cytoid bodies were seen in the active and chronic stages. In 1 patient, numerous cytoid bodies were noted in an active stage but none was seen when the patient returned to hospital 9 years later with another illness.
Other findings are listed in Table 5 . The following patient is of interest because of unusually prominent papille dema which regressed together with other signs of SLE when prednisone treat ment was started.
Case (10) : This 18 year old female was admitted to The Johns Hopkins Hospital in September 1961 because of fever, cough, anorexia, weight loss and severe throbbing headache of 3 months duration.
Examination revealed fever of 102.6, markedly swollen optic discs, pustules over her face, generalized lymphadenopathy, rales at both lung bases. No hemorrhage or exudate was noted in fundi.
Laboratory studies revealed many typical L-E cells in the peripheral blood, anemia with hematocrit of 27, elevation of sedimentation rate to 34, inverted serum albumin globulin ratio, marked albuminuria and micros copic hematuria. Serum urea nitrogen was normal. Lumbar puncture was done and the opening pressure was 410 mm. Fluid was clear and contained 3 white blood cells and 2 red blood cells per cubic millimeter.
Protein was 10 mg%. Electroencephalography and cerebral scintiscan failed to reveal any evidence of intracranial mass lesion. She was started on prednisone and papilledema gradu ally regressed. On the 18th hospital day lumbar puncture revealed normal pres sure. By the 26th hospital day, the disc margin was only slightly blurred, at which time she was discharged on prednisone.
In hospital, albuminuria and anemia also responded to the treatment. In the following 1.5 years no further evidence of papilledema, increased intracranial pressure or other neurological abnormality was noted. These changes were seen in the small arteries, arterioles, veins of the brain, spinal cord, peripheral nerves and of the meninges. Only in 1 case, was involvement of the trunk of a major cerebral artery noted. Generally these vascular changes were scattered and sporadic. Of these 28 cases with the vascular changes, 17 cases were found to have scattered foci of softening.
In 5 cases, the softening and the vascular changes were limited to 1 area.
Six of 19 cases without vascular chaanges showed various kinds of intracranial hemorrhage. These included 2 cases of subarachnoid hemorrhage, 2 cases of subdural hemorrhage (one associated with intracerebral hemorrhage) and 2 cases of diffuse petechial hemorrhages. The source of the hemorrhages was not clear. Four cases had meningitis and intra cerebral abscesses. In 6 other cases, nonspecific changes such as edema, micros copic foci of spongy degeneration, perivaseular degeneration and infiltration were seen. In 2 cases, macroscopic and miscroseopic examination failed to reveal any lesion.
Larson54) reported the following neuropathological findings in 41 patients with SLE. Among 22 patients in whom no neurological or psychiatric deficit was clinically evident, 9 had focal areas of encephalomalacia with varying degrees of arteritis.
Of 19 patients with neurologic signs and symptoms, 8 had no pathological abnormalities. Seven patients had multiple focal areas of eneepha lomalacia with varing degrees of arteritis, three infection and one peripheral neuritis. They represent involvement at all levels of neuraxis and range from encephalopathy to myopathy and retinopathy. Several attempts have been made to reveal true incidence of these signs and symptoms and the present study was undertaken with an intention to delineate the neurological aspect of the disease more clearly.
The most controversial subject in regard to the neurological aspect has been the question if these signs and symptoms are mainly products of the neurological involvement by the disease or rather side effects of the adrenocorticosteroid treat ment. The present review indicates that generally neurological involvements are directly related to SLE, developing together with systemic signs of the disease or responding to the treatments for SLE. However, in a significant number of cases with convulsions, psychoses and myopathy characterized by weakness, the symptoms seem to be more closely related to steroid treatment, convulsions and psychoses occurring within days and myopathy within weeks to months after institution or increase of steroid ,treatment and improving when, the treatment is withdrawn. This was most obvious in cases with psychoses in this study, as 4 out of 9 patients with the symptom developed it within several days after institution or increase of steroid treatment and all of them improved when steroid dosage was reduced. Another patient became-psychotic when on a "con stant dose of steroid, did not respond to increase in steroid dosage and improved when it was reduced. O'Connor's study of 21 psychotic patients is in agreement with the present study in this point. 
